Healthcare & Life Sciences
Aurealis Therapeutics
Switzerlandaurealistherapeutics.com
Aurealis Therapeutics is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series B, 4 tracked investors.
Activeseries-b
series-b
Stage
2018
Founded
4
Investors
About Aurealis Therapeutics
Aurealis Therapeutics is a company founded in 2018 headquartered in Switzerland. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Aurealis Therapeutics develops scalable multi-target cell and gene therapies that modulate tissue microenvironments to treat chronic wounds, cancers, and inflammatory diseases, with clinical-stage programs including AUP-16 for diabetic foot ulcers and AUP-55 for cancer.
Explore Aurealis Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.